SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is experiencing significant volatility driven by escalating Middle East tensions, fueling community debate between fears of a broader market correction from rising oil prices and inflation, and conviction that the dip presents a buying opportunity.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp (BATL) is soaring on heightened geopolitical tensions surrounding oil supply routes and rising crude prices, igniting a powerful short squeeze as its low float attracts massive retail attention and bullish price targets.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

Escalating geopolitical tensions in the Middle East, especially around the Strait of Hormuz and its potential impact on oil prices, are driving significant volatility for QQQ. The community is sharply divided, with some anticipating a deeper market correction while others point to resilient 'buy the dip' behavior and perceived market manipulation.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Escalating geopolitical tensions surrounding the Iran conflict and rising crude oil prices, exacerbated by reports of the Strait of Hormuz closure, are driving conversation around Indonesia Energy Corp Ltd (INDO). The community anticipates a significant short squeeze and a major run, similar to other surging energy stocks, as traders rotate profits into INDO.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

Amidst escalating geopolitical tensions, iShares Silver Trust ($SLV) is experiencing a sharp selloff, leading to intense community debate about its 'safe haven' status and widespread accusations of market manipulation. Many investors are seeing the dip as a significant buying opportunity, citing underlying physical supply shortages and robust industrial demand from the AI sector as bullish long-term drivers.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending due to surging safe-haven demand amidst escalating Middle East tensions and concerns over global stability, with the community actively debating if this marks a sustained gold rally or a temporary geopolitical spike.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is actively trending as its dedicated community anticipates significant cultural and market momentum surrounding the upcoming 4/20, emphasizing the crypto's long-term vision for cannabis freedom and decentralization on Solana, and believing in its steady growth as a resilient "culture coin."

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group Inc. is trending after reporting record-breaking full-year 2025 revenue and significant profitability improvements, backed by a multi-billion dollar AI infrastructure pipeline and strong cash reserves. Despite these positive fundamentals, the community is sharply divided, with many bulls expressing frustration over the stock's persistent undervaluation while skeptics question financial transparency and the lack of corresponding price appreciation.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending as community conversation is dominated by the ongoing military operation in Iran, which many users are actively discussing as a strategic move to divert attention from recent developments regarding the Epstein files. This conflict fuels intense debate, with some viewing it as a strong, proactive measure, while others criticize the administration's rationale and potential for escalating global instability.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending following its uplisting to the Nasdaq Global Select Market and reports of accelerating sales and expanding formulary coverage for its fibromyalgia drug, Tonmya. The community sees this as a de-risking milestone, fueling discussions on potential for a significant re-rating and short squeeze, as bullish investors highlight strong institutional accumulation against concerns of past dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

In this photo illustration, a smartphone displays the logo of UnitedHealth Group Incorporated. (Photo illustration by Cheng Xin/Getty Images)

UNH Stock Slides Pre-Market: United Health Warns Of Softer FY26 As Medicare Pressures Mount 

UnitedHealth expects revenue in 2026 of around $439 billion, a 2% year-over-year decline.

Equity

Be Thankful to These ETFs This Year 

Be thankful for this year's resilient ETFs -- BWET, LITP, PINK and CANC -- which shined despite volatility, tariffs, AI worries and Fed shifts.

Shares of Leap Therapeutics, Inc. nosedived more than 70% to an all-time low on Tuesday, making them the top loser across U.S. exchanges.The sharp drop — Leap’s worst intraday fall ever — came after the biotech firm announced it would terminate further development of sirexatamab in gastric cancer trials while shifting its focus to colorectal cancer (CRC).Leap reported data from the Phase 2 DeFianCe trial, which evaluated sirexatamab in combination with bevacizumab (Avastin) and chemotherapy for CRC.&nbsp;The trial showed an objective response rate (ORR) of 35% and a disease control rate (DCR) of 86%, slightly outperforming the control group (ORR: 23%, DCR: 84%). Preparations are now underway for a Phase 3 study targeting second-line CRC patients.However, results from the DisTinGuish study for gastric and gastroesophageal junction (GEJ) cancers were less promising.&nbsp;While sirexatamab combined with tislelizumab (BeiGene’s anti-PD-1 antibody) and chemotherapy showed some activity in biomarker-specific populations, the study failed to generate a clear positive signal on progression-free survival (PFS) endpoints.Chief Medical Officer Cynthia Sirard cited challenges in radiological assessments and high discordance between investigator assessments and blinded independent central review (BICR) as reasons for the trial’s disappointing outcome.“Therefore, we have decided to focus our internal effort and resources on advancing sirexatamab in CRC and will explore strategic partnership opportunities to advance sirexatamab plus anti-PD-1 antibodies in gastric cancer and other indications where there is high DKK1 expression,” she said.Despite the stock’s dramatic plunge, retail chatter on Stocktwits revealed optimism about the CRC pipeline, with several hoping for a potential turnaround as Phase 3 trials progress.<stembedurl>https://stocktwits.com/inphatec1/message/601848582</stembedurl><stembedurl>https://stocktwits.com/Walter100/message/601825571</stembedurl>Leap ended the third quarter of 2024 with $62.8 million in cash, which it believes&nbsp;is sufficient to fund operations into the second quarter of 2026.The stock has lost over 72% in the past 12 months, including a 7.8% year-to-date decline before this session.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stockbroker analyzing financial stock market with reflection on eyeglasses. Photo via Westend61 on Getty Images

Leap Therapeutics Stock Plunges To Record Low After Ending Gastric Cancer Drug Trials, Retail Bets On CRC Pipeline

While sirexatamab combined with tislelizumab and chemotherapy showed some activity in biomarker-specific populations, the study failed to generate a clear positive signal on progression-free survival endpoints.

Simplify Exchange Traded Funds - Simplify Health Care ETF

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $MDB earnings today?

PINK
Simplify Exchange Traded Funds - Simplify Health Care ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest PINK News

PINKSimplify Exchange Traded Funds - Simplify Health Care ETF